Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pharmacodynamics and proteomic analysis of acalabrutinib therapy: Similarity of on-target effects to ibrutinib and rationale for combination therapy
Leukemia ( IF 11.4 ) Pub Date : 2017-11-03 , DOI: 10.1038/leu.2017.321 V K Patel , B Lamothe , M L Ayres , J Gay , J P Cheung , K Balakrishnan , C Ivan , J Morse , M Nelson , M J Keating , W G Wierda , J R Marszalek , V Gandhi
Leukemia ( IF 11.4 ) Pub Date : 2017-11-03 , DOI: 10.1038/leu.2017.321 V K Patel , B Lamothe , M L Ayres , J Gay , J P Cheung , K Balakrishnan , C Ivan , J Morse , M Nelson , M J Keating , W G Wierda , J R Marszalek , V Gandhi
Pharmacodynamics and proteomic analysis of acalabrutinib therapy: Similarity of on-target effects to ibrutinib and rationale for combination therapy
中文翻译：
acalabrutinib治疗的药效学和蛋白质组学分析：靶点作用与ibrutinib的相似性以及联合治疗的原理
acalabrutinib治疗的药效学和蛋白质组学分析：靶点作用与ibrutinib的相似性以及联合治疗的原理
更新日期：2017-11-03
Pharmacodynamics and proteomic analysis of acalabrutinib therapy: Similarity of on-target effects to ibrutinib and rationale for combination therapy, Published online: 03 November 2017; doi:10.1038/leu.2017.321
中文翻译：
acalabrutinib治疗的药效学和蛋白质组学分析：靶点作用与ibrutinib的相似性以及联合治疗的原理
acalabrutinib治疗的药效学和蛋白质组学分析：靶点作用与ibrutinib的相似性以及联合治疗的原理
acalabrutinib疗法的药效学和蛋白质组学分析：目标作用与ibrutinib的相似性以及联合疗法的原理，在线发表：2017年11月3日；doi：10.1038 / leu.2017.321
京公网安备 11010802027423号